Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Docetaxel and Mitoxantrone Prior to Prostatectomy in High Risk Localized Prostate Cancer
NCT00017563Phase 2Completed
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Sep 2000
- Primary completion
- May 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of mitoxantrone in prostate cancer (PCa), sponsored by OHSU Knight Cancer Institute. Started Sep 2000; status: completed.
02
Drugs
mitoxantrone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00017563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017563.